US2006229331A1PendingUtilityA1
Ketoprofen compositions and methods of making them
Individually held — no corporate assignee on recordPriority: Dec 13, 2002Filed: Jun 19, 2006Published: Oct 12, 2006
Est. expiryDec 13, 2022(expired)· nominal 20-yr term from priority
Inventors:Ronald Haas
A61K 9/0095A61K 9/0014A61K 9/0019A61K 9/02A61K 47/10
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A wide variety of pharmaceutically and commercially acceptable dosage forms of ketoprofen are prepared by dissolving ketoprofen in pharmaceutically acceptable solvents.
Claims
exact text as granted — not AI-modified1 . A clear and stable aqueous solution, comprising a predetermined therapeutically effective amount of an alkali metal salt of ketoprofen dissolved in an aqueous medium.
2 . The aqueous solution of claim 1 , in which the therapeutically effective amount of ketoprofen salt is a mass equivalent of about 12.5 mgs to 150 mgs of ketoprofen per 5 ml of aqueous solution.
3 . The aqueous solution of claim 1 , in which there is no particulate matter evident in the solution upon visual examination.
4 . A palatable solution in accordance with claim 1 , which has a substantially reduced flavor of ketoprofen without additional flavoring agents.
5 . The solution of claim 1 , further comprising a flavoring agent.
6 . The solution of claim 1 , further comprising a sweetening agent.
7 . The solution of claim 1 , further comprising sucrose.
8 . The solution of claim 1 , further comprising sorbitol.
9 . The solution of claim 1 , further comprising glycerin.
10 . The solution of claim 1 , further comprising artificial sweetener.
11 . The solution of claim 10 , in which the artificial sweetener is saccharine.
12 . The solution of claim 1 , further comprising a preservative composition.
13 . A colorless solution in accordance with claim 1 .
14 . A pharmaceutically acceptable and palatable oral dosage form of ketoprofen comprising the solution of claim 1 .
15 . The solution of claim 1 , further comprising an additional medication.
16 . The solution of claim 15 , in which the additional medication is a narcotic composition.
17 . The solution of claim 16 , in which the narcotic composition is hydrocodone.Join the waitlist — get patent alerts
Track US2006229331A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.